Young Jonathan
SEC insider (Form 3/4/5 filer). CIK 0001779805. Chief Operating Officer at Akero Therapeutics, Inc. (AKRO). 44 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in SOUTH SAN FRANCISCO, CA.
Companies Young Jonathan has filed insider reports for
- Akero Therapeutics, Inc. (AKRO): Officer, Chief Operating Officer
Young Jonathan
CIK: 0001779805
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Akero Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (44 total)
- Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionIndirect20K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionIndirect20K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionIndirect20K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect152.6K shares- - Dec 9, 2025AKRO
Akero Therapeutics, Inc.
DispositionDirect47.6K shares- - Nov 26, 2025AKRO
Akero Therapeutics, Inc.
GiftDirect9.3K shares- - Nov 24, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect4.7K shares at avg. $21.10$100K - Nov 24, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect3.5K shares at avg. $28.35$100K - Nov 24, 2025AKRO
Akero Therapeutics, Inc.
ExerciseDirect4.3K shares at avg. $21.09$90K - Oct 1, 2025AKRO
Akero Therapeutics, Inc.
SaleDirect4.2K shares at avg. $47.98$202K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 20,000 | - | - | Indirect |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 20,000 | - | - | Indirect |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 20,000 | - | - | Indirect |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 152,616 | - | - | Direct |
| Dec 9, 2025 | AKRO Akero Therapeutics, Inc. | Disposition | 47,573 | - | - | Direct |
| Nov 26, 2025 | AKRO Akero Therapeutics, Inc. | Gift | 9,259 | - | - | Direct |
| Nov 24, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 4,739 | $21.10 | $99,993 | Direct |
| Nov 24, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 3,527 | $28.35 | $99,990 | Direct |
| Nov 24, 2025 | AKRO Akero Therapeutics, Inc. | Exercise | 4,284 | $21.09 | $90,350 | Direct |
| Oct 1, 2025 | AKRO Akero Therapeutics, Inc. | Sale | 4,201 | $47.98 | $201,581 | Direct |
1-10 of 44 transactions